Projects per year
Personal profile
Biography
Dr Elizabeth Moore is Research Fellow and Project Manager of the Myeloma and Related Diseases Registry (MRDR) in the SPHPM, and has been heavily involved in the growth and increasing productivity of the registry and the Myeloma 1000 Biobank. She is investigator on various MRDR-based projects including the MRFF-funded epidemiological modelling study to anticipate future needs and deliver better care for Australians with multiple myeloma, and the IMPROVE study to describe immunoglobulin use, and inform policy and future stewardship of this resource in Australia. She also provides support to an expanding and diverse range of MRDR studies http://www.mrdr.net.au/projects/.
Elizabeth led the My-PROMPT trial, a randomised controlled trial to test the feasibility of real-time feedback of patient-reported outcomes (PROs) to clinicans treating patients with multiple myeloma. This was the first trial of its kind in a cohort with blood cancer and results informed the recently MRFF-funded MY-PROMPT-2 trial assessing whether real-time feedback of PROs to clinicians improves duration on therapy in patients with relapsed myeloma receiving standard of care, compared to standard of care alone.
Elizabeth has extensive experience managing the complex needs of critically ill cancer patients as a critical care nurse, is a current member of the Research Standing Committee of the Cancer Nurses Society of Australia (CNSA) and the Research Advisory Panel of the Australian College of Critical Care Nurses (ACCCN), and has been a member of the ACCCN Victorian Management Committee (2012-2018). She is a current member of the Research Governance Committee for the SPHPM.
She reviews applications for the ACCCN and ANZ Intensive Care Foundation grants, abstracts for the CNSA Annual Congress and the joint ANZ Intensive Care Society-ACCCN Annual Scientific Meeting, and participates in PhD graduate review panels in the School of Public Health and Preventive Medicine. She has reviewed manuscripts for numerous journals including Cancer Medicine and Lancet Haematology.
Research Projects
Myeloma and Related Diseases Registry http://www.mrdr.net.au/
My-PROMPT: Patient Reported Outcome Measures in multiple myeloma: real-time rePorTing to improve care http://www.mrdr.net.au/projects/
IMPROVE: Immunoglobulins in Myeloma Patients: Research into Outcomes, Variation in practice, and Epidemiology http://www.mrdr.net.au/projects/
Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR) https://apacmrdr.org/
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, MONASH UNIVERSITY
MPH, University of Melbourne
PGDipNurs (Crit Care), University of Melbourne
Research area keywords
- Myeloma
- Registries
- Patient-reported outcomes
- Quality Of Life
- Clinical trials
- Supportive care
Network
-
More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial
Spencer, A., Rutherford, C., Reynolds, J., Ho, P. J., McQuilten, Z., Moore, E., King, T. A., Wood, E., Harrison, S. J. & Irving, A.
Department of Health (Australia)
1/02/22 → 31/01/27
Project: Research
-
Incidence and clinical outcomes of functional high-risk multiple myeloma patients in Australia
Wood, E., Moore, E. & McQuilten, Z.
25/10/21 → 30/06/22
Project: Research
-
A Retrospective Database Analysis of an Ongoing Registry Study To Evaluate The Impact Of Daratumumab (Darzalex) Combined With Bortezomib-Dexamethasone (DVd) In Patients With Relapsed/Refractory Multiple Myeloma (RRMM) In Australia
Wood, E., Spencer, A., Moore, E. & McQuilten, Z.
Janssen-Cilag Pty Ltd (Australia)
1/05/21 → 31/03/24
Project: Research
-
A Retrospective Study to Describe the Characteristics and outcomes of patients participating in the Australia & New Zealand Myeloma and Related Diseases Registry (MRDR) matched to eligibility criteria for the CARTITUDE
Wood, E., Spencer, A., McQuilten, Z. & Moore, E.
Janssen-Cilag Pty Ltd (Australia)
3/11/21 → 30/01/22
Project: Research
-
Data analysis and report from Myeloma and Related Diseases Registry
Wood, E., Moore, E. & McQuilten, Z.
25/02/21 → 3/03/21
Project: Research
-
A Post Hoc Analysis of Osmotherapy Use in the Erythropoietin in Traumatic Brain Injury Study-Associations With Acute Kidney Injury and Mortality
Skrifvars, M., Bailey, M., Moore, E. M., Mårtensson, J., French, C., Presneill, J. J., Nichol, A., Little, L., Duranteau, J., Huet, O., Haddad, S., Arabi, Y., McArthur, C., Cooper, D. J., Bendel, S., Bellomo, R. & for the Erythropoietin in Traumatic Brain Injury (EPOTBI) Investigators and the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group, Apr 2021, In: Critical Care Medicine. 49, 4, p. e394-e403 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial
Eisen, D. P., Leder, K., Woods, R. L., Lockery, J. E., McGuinness, S. L., Wolfe, R., Pilcher, D., Moore, E. M., Shastry, A., Nelson, M. R., Reid, C. M., McNeil, J. J. & McBryde, E. S., Feb 2021, In: The Lancet Respiratory Medicine. 9, 2, p. 186-195 10 p.Research output: Contribution to journal › Article › Research › peer-review
20 Citations (Scopus) -
Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study
Wiegers, E., Lingsma, H., Huijben, J., Cooper, D. J., Citerio, G., Frisvold, S., Helbok, R., Maas, A. I. R., Menon, D., Moore, E. M., Stocchetti, N., Dippel, D. W., Steyerberg, E. W., van der Jagt, M. & on behalf of the CENTER-TBI and OzENTER-TBI Collaboration Groups, Aug 2021, In: The Lancet Neurology. 20, 8, p. 627-638 12 p.Research output: Contribution to journal › Article › Research › peer-review
6 Citations (Scopus) -
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
Bergin, K., Wellard, C., Augustson, B., Cooke, R., Blacklock, H., Harrison, S. J., Ho, J., King, T., Quach, H., Mollee, P., Walker, P., Moore, E., McQuilten, Z., Wood, E., Spencer, A. & on behalf of the Australian and New Zealand Myeloma and Related Diseases Registry, Oct 2021, In: Bone Marrow Transplantation. 56, 10, p. 2533-2543 11 p.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction
Boyle, S., Wellard, C., Moore, E. M., Blacklock, H., Harrison, S. J., Ho, P. J., Hocking, J., McQuilten, Z. K., Quach, H., Spearing, R., Wood, E. M., Spencer, A., Mollee, P. & Myeloma and Related Diseases Registry investigators, Oct 2021, In: European Journal of Haematology. 107, 4, p. 497-499 3 p.Research output: Contribution to journal › Letter › Other › peer-review
Prizes
-
Snowdome Foundation - Haematology Nurse Myeloma Travel Grant $2500
Moore, Elizabeth (Recipient), 23 Oct 2018
Prize: Prize (including medals and awards)
-
International Myeloma Workshop 2019
Elizabeth Moore (Speaker)
12 Sep 2019 → 15 Sep 2019Activity: Participating in or organising an event types › Contribution to conference
-
Blood 2019
Elizabeth Moore (Speaker)
20 Oct 2019 → 23 Oct 2019Activity: Participating in or organising an event types › Contribution to conference
-
Myeloma UK Patient Registry Stakeholder Workshop
Elizabeth Moore (Invited speaker)
10 Apr 2019Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
Clinical Registries Summit
Elizabeth Moore (Invited speaker)
26 Nov 2018Activity: Participating in or organising an event types › Contribution to conference
-
Myeloma Registries: Denmark and ANZ
Elizabeth Moore (Invited speaker)
11 Jul 2018Activity: Participating in or organising an event types › Contribution to workshop, seminar, course